Zymergen to Report Third Quarter 2021 Financial Results on November 3, 2021

10/26/21 4:05:00 PM ET

Industrial Specialties

Industrials

Get the next $ZY alert in real time by email

EMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (NASDAQ:ZY) today announced it will report financial results for the third quarter 2021 after market close on Wednesday, November 3rd, 2021. The company's management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.

A webcast of the conference call can be accessed at https://investors.zymergen.com/.

About Zymergen

Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.

Investor Contact

Carrie Mendivil/Mary Kate McDonough

[email protected]

Media Contact

Mike Dulin

[email protected]

502-777-2029

Get the next $ZY alert in real time by email

Date	Price Target	Rating	Analyst
3/2/2022		Market Perform	Cowen
1/12/2022	$6.50	Reduce → Hold	HSBC Securities
10/15/2021		Market Perform	Cowen
9/27/2021	$12.00	Neutral → Underweight	JP Morgan
8/31/2021	$56.00 → $13.00	Buy → Neutral	UBS
8/4/2021	$43.00 → $7.00	Buy → Underperform	BofA Securities
8/4/2021		Outperform → Market Perform	Cowen & Co.
8/4/2021	$55.00 → $12.00	Buy → Neutral	Goldman Sachs

Zymergen to Report Third Quarter 2021 Financial Results on November 3, 2021

Chat with this insight

Recent Analyst Ratings for
$ZY

$ZY
Press Releases

Fastest customizable press release news feed in the world

Ginkgo Bioworks Completes Acquisition of Zymergen

Ginkgo to Acquire Zymergen

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

$ZY
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4: Svf Excalibur (Cayman) Ltd disposed of 26,614,219 shares

SEC Form 4: Flatley Jay T returned 144,789 shares to the company, closing all direct ownership in the company

SEC Form 4: Chu Steven returned 50,000 shares to the company, closing all direct ownership in the company

$ZY
SEC Filings

SEC Form 15-12G filed by Zymergen Inc.

SEC Form EFFECT filed by Zymergen Inc.

SEC Form POS AM filed by Zymergen Inc.

$ZY
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Zymergen Inc. (Amendment)

SEC Form SC 13G filed by Zymergen Inc.

SEC Form SC 13G filed by Zymergen Inc.

$ZY
Market Insights

Live Market Insights

Zymergen Announced Further Reduction In Force That Is Expected To Result In The Termination Of About 110 Employees; Estimates It Will Incur Cash-Based Severance Costs Of About $7.9M Related To The October 2022 Reduction In Force

Shares of metals, mining and chemicals companies are trading higher amid overall market strength as stocks continue to rebound following September's selloff. Ongoing Fed monetary policy tightening and broader economic concerns have weighed on materials demand outlook.

Nu Holdings, Ally Financial And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

$ZY
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Cowen resumed coverage on Zymergen

Zymergen upgraded by HSBC Securities with a new price target

Cowen resumed coverage on Zymergen

$ZY
Financials

Live finance-specific insights

Ginkgo to Acquire Zymergen

Zymergen Reports Preliminary First Quarter 2022 Financial Results

Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022

Zymergen to Report Third Quarter 2021 Financial Results on November 3, 2021

Chat with this insight

Recent Analyst Ratings for $ZY

$ZY Press Releases

Fastest customizable press release news feed in the world

Ginkgo Bioworks Completes Acquisition of Zymergen

Ginkgo to Acquire Zymergen

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

$ZY Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4: Svf Excalibur (Cayman) Ltd disposed of 26,614,219 shares

SEC Form 4: Flatley Jay T returned 144,789 shares to the company, closing all direct ownership in the company

SEC Form 4: Chu Steven returned 50,000 shares to the company, closing all direct ownership in the company

$ZY SEC Filings

SEC Form 15-12G filed by Zymergen Inc.

SEC Form EFFECT filed by Zymergen Inc.

SEC Form POS AM filed by Zymergen Inc.

$ZY Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Zymergen Inc. (Amendment)

SEC Form SC 13G filed by Zymergen Inc.

SEC Form SC 13G filed by Zymergen Inc.

$ZY Market Insights

Live Market Insights

Zymergen Announced Further Reduction In Force That Is Expected To Result In The Termination Of About 110 Employees; Estimates It Will Incur Cash-Based Severance Costs Of About $7.9M Related To The October 2022 Reduction In Force

Shares of metals, mining and chemicals companies are trading higher amid overall market strength as stocks continue to rebound following September's selloff. Ongoing Fed monetary policy tightening and broader economic concerns have weighed on materials demand outlook.

Nu Holdings, Ally Financial And Some Other Big Stocks Moving Higher In Today's Pre-Market Session

$ZY Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Cowen resumed coverage on Zymergen

Zymergen upgraded by HSBC Securities with a new price target

Cowen resumed coverage on Zymergen

$ZY Financials

Live finance-specific insights

Ginkgo to Acquire Zymergen

Zymergen Reports Preliminary First Quarter 2022 Financial Results

Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022

Recent Analyst Ratings for
$ZY

$ZY
Press Releases

$ZY
Insider Trading

$ZY
SEC Filings

$ZY
Large Ownership Changes

$ZY
Market Insights

$ZY
Analyst Ratings

$ZY
Financials